ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Victor A. Jebara
Alain F. Carpentier
Jean-Noël Fabiani
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chardigny, C. I.
Right arrow Articles by Fabiani, J.-N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chardigny, C. I.
Right arrow Articles by Fabiani, J.-N.

Ann Thorac Surg 1998;66:466-470
© 1998 The Society of Thoracic Surgeons


Original articles: cardiovascular

Effects of cardioplegic solutions on the vasoreactivity of the internal mammary artery

Catherine I. Chardigny, MDa, Victor A. Jebara, MDa, Tony J. Verbeuren, PhDb, Alain F. Carpentier, MD, PhDa, Jean-Noël Fabiani, MDa

a Department of Cardiovascular Surgery, Broussais Hospital, Paris, France
b Servier Research Institute, Suresnes, France

Accepted for publication March 21, 1998.

Address reprint requests to Dr Fabiani, Département de Chirurgie Cardio-vasculaire, Hôpital Broussais, 96, rue Didot, 75014 Paris, France

Background. During free internal mammary artery grafting, cardioplegia administration can be performed through the internal mammary artery. The present study examined whether cardioplegic solutions produce arterial graft constriction and functional endothelial damage.

Methods. Forty internal mammary artery segments from 10 patients were incubated in Krebs solution (n = 10), University of Wisconsin solution (n = 10), Broussais Hospital solution (n = 10), or blood cardioplegia (n = 10).

Results. There was a significant difference in sensitivity to norepinephrine between segments in Krebs solution and those in University of Wisconsin solution or Broussais Hospital solution but not segments in blood cardioplegia. There was a significant difference in relaxation to acetylcholine between segments in Krebs solution and those in the three other cardioplegic solutions and between those in blood cardioplegia and segments in University of Wisconsin solution or Broussais Hospital solution. There was no significant difference in relaxation to sodium nitroprusside between segments in any of the solutions.

Conclusions. These experiments suggest that storage in the different cardioplegic solutions studied does not preserve the initial vasoreactivity of the internal mammary artery. However, blood cardioplegia appears to be less deleterious in regard to endothelial and myogenic vascular function.




This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
P. J. Pearson and H. V. Schaff
Effects of cardioplegic solutions on vasoreactivity of the internal mammary artery
Ann. Thorac. Surg., August 1, 1998; 66(2): 311 - 312.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1998 by The Society of Thoracic Surgeons.